Literature DB >> 1384971

Structure of the polysaccharide O-antigen of Salmonella riogrande O:40 (group R) related to blood group A activity.

M B Perry1, L L MacLean.   

Abstract

The structure of the Salmonella O:40 (Group R) antigen was determined from an analysis of the antigenic O-polysaccharide component of the lipopolysaccharide produced by Salmonella riogrande O:40. Using 1H- and 13C-NMR spectroscopy, methylation analysis, and periodate degradation methods, the O-polysaccharide was found to be a high molecular weight branched polymer of repeating pentasaccharide units having the structure: [formula: see text] The reported human blood group A activity was concluded to reside in an epitope of a terminal trisaccharide portion of the O-chain involving alpha-D-GalpNAc and beta-D-GlcpNAc residues linked (1----3) and (1----2), respectively, to beta-D-Manp branched residues in which the alpha-D-GalpNAc residue would appear to be the critical antigenic factor recognized by polyclonal blood group A antisera.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1384971     DOI: 10.1016/s0008-6215(00)91001-2

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  3 in total

1.  Study of matrix additives for sensitive analysis of lipid A by matrix-assisted laser desorption ionization mass spectrometry.

Authors:  Ping Zhou; Eleonora Altman; Malcolm B Perry; Jianjun Li
Journal:  Appl Environ Microbiol       Date:  2010-04-09       Impact factor: 4.792

2.  Identification and differentiation of Taylorella equigenitalis and Taylorella asinigenitalis by lipopolysaccharide O-antigen serology using monoclonal antibodies.

Authors:  Brian W Brooks; Cheryl L Lutze-Wallace; Leann L Maclean; Evgeny Vinogradov; Malcolm B Perry
Journal:  Can J Vet Res       Date:  2010-01       Impact factor: 1.310

Review 3.  The structural diversity of carbohydrate antigens of selected gram-negative marine bacteria.

Authors:  Evgeny L Nazarenko; Russell J Crawford; Elena P Ivanova
Journal:  Mar Drugs       Date:  2011-10-14       Impact factor: 6.085

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.